Back to Directory

Revivocell

NANOSTACKS organ models for preclinical drug safety research

Revivocell is a Lancaster University spin-out developing modular human microphysiological systems for preclinical drug discovery and toxicology.

Its NANOSTACKS platform uses stackable cell-culture modules to assemble multilayer tissue models, including liver, neuronal and interconnected organ systems.

The company provides research platforms and customised in vitro studies covering hepatotoxicity, drug metabolism and neurotoxicity. Based at Sci-Tech Daresbury, its technology aims to improve preclinical testing while reducing dependence on animal models.

Company Notes